肝細胞性肝癌 的英文怎麼說

中文拼音 [gānxìbāoxìnggānái]
肝細胞性肝癌 英文
hepatocellular carcinoma
  • 肝 : 名詞（人和高等動物的消化器官之一） liver
  • 細 : 形容詞1 （條狀物橫剖面小） thin; slender 2 （顆粒小） in small particles; fine 3 （音量小） thin ...
  • 胞 : Ⅰ名詞1 （胞衣） afterbirth2 （同一個國家或民族的人） fellow countryman; compatriot Ⅱ形容詞（同胞...
  • 性 : Ⅰ名詞1 （性格） nature; character; disposition 2 （性能; 性質） property; quality 3 （性別） sex ...
  • 癌 : 名詞[醫學] （惡性腫瘤） cancer; carcinoma
  • 細胞 : cell; sytes; bioplast; cella; [口語] gene; [生物學] cellule; cellule cellulli cellulo ; cello ; k...
  • 肝癌 : [醫學] cancer of the liver
  1. Alphafetoprotein production is only seen in liver cell carcinoma.

    甲胎蛋白的產生只見于肝細胞性肝癌。
  2. Objective to study the effects of volatileoil, curcumenol, curzerenone and isocurcumenol from curcuma phaeocaulis valeton on liver cancer and endometrial carcinoma cell lines

    摘要目的對中藥蓬莪術揮發油及其中3種主要化學成分莪術烯醇、莪術酮和異莪術烯醇進行抗肝癌和子宮內膜癌細胞活性的研究。
  3. Capacity of bone induction of compound material of decalcified bone matrix combined with rhbmp - 2 and impregnated with bone cement

    凋亡相關基因表達對肝細胞癌生物特性及預后的影響
  4. Identification of phage displayed peptides specifically binding to high liver - metastatic gastric cancer cells

    胃癌肝高轉移細胞結合肽的特異性鑒定
  5. Study on immunoreaction induced by dcs loaded with hepatocarcinoma antigen peptide in vitro

    樹突狀細胞負載肝癌抗原肽疫苗體外誘導特異性免疫學反應的研究
  6. The malignant cells of this hepatocellular carcinoma ( seen mostly on the right ) are well differentiated and interdigitate with normal, larger hepatocytes ( seen mostly at the left )

    該肝細胞癌的惡性腫瘤細胞（主要位於右方）分化較好，並與較大的正常肝細胞（主要位於左方）相互交錯。
  7. From different points of view of the epidemiology, cytogenetics, molecular biology, experimental pathology and preventive medicine, this study revealed and proved that the genotoxicity and carcinogenesis existed in the drinking pond water in the high incidence area of live cancer in guangxi, indicated the feasible preventive and interruptive methods, too

    從分析流行病學，細胞遺傳毒理學、分子生物學、實驗病理學和預防醫學的不同角度，揭示和論證了廣西某肝癌高發區居民飲用塘水的基因毒性和致癌性，提出了切實可行的預防和阻斷措施。
  8. Results in the 260 slices of liver biopsy, there were 20 ones of acute viral hepatitis, 78 ones of chronic hepatitis, 79 ones of hepatocirrhosis, 28 ones of primary liver cell cancer, 27 ones of liver karyon heterogeneity, 20 ones of liver metastatic adenocarcinoma, 12 ones of fatty liver, five ones of alcohol liver, three ones of liver cyst, two ones of congenital bile duct atresia, six ones of illegible structure, 20 ones without liver cell or with few scattered liver cell

    結果260例肝穿活檢組織病例中，急性（病毒性）肝炎20例；慢性肝炎78例；肝硬化39例；原發性肝細胞癌28例；肝細胞核異質27例；肝轉移性腺癌20例；脂肪肝12例；乙醇肝5例；肝囊腫3例；先天性膽管閉鎖2例；穿刺組織結構模糊6例；未穿到或僅穿到少量肝細胞20例。
  9. Five analogues and five segments were designed and synthesized by using solid phase synthesis method according to separated papaver somniferum pollen tridecapeptide with antitumor activities as leading peptide. their primary secondary structures in solution were determined by cd spectra and their inhibitive activities to human liver and mammary gland cancer cells were assayed by mtt method. the relationship of structure - activity was studied and discussed

    罌粟花粉十三肽對人肝癌和人乳腺癌腫瘤細胞具有明顯的抑制作用，以其為先導化合物，設計併合成了5個類似物和5個片段，結合cd譜測定的二級結構及它們對人肝癌和人乳腺癌腫瘤細胞的抑制作用測定結果，研究並討論了該肽結構與抗腫瘤活性的關系
  10. Selenium had cooperativity for immobilized pc in certain concentrations. the co - immobilization of other proteins inhibited the cancer inhibition activity of pc, enhanced liver cancer cells growth. photo - chemical immobilization of pc also inhibited pancreatic cancer sw1990 cells growth effectively with 40 % inhibition rate

    螺旋藻中其它蛋白質的共固定化，抑制藻藍蛋白的抑癌活性，表現為藻總蛋白（ asp ）光固定化pst膜對肝癌細胞生長有營養促進作用。
  11. After adding culture mediem of stably transfected jurkat cells to hepatocarcinoma cells, the binding specificity of the scfvs with hbsag was further confirmed by observation by fluorescence microscope, indirect immunofluorescence and flow cytometer analysis. prokaryotic expression plasmids ptat - ha - scfvs were successfully constructed

    建系細胞培養上清與肝癌細胞作用后，經熒光顯微鏡觀察、間接免疫熒光及流式細胞儀檢測進一步確定表達的scfv融合蛋白具有與hbsag特異性結合的活性。
  12. Diagnosis and treatment of - fetoprotein - negative small hepatocellular carcinoma

    甲胎蛋白陰性小肝細胞癌的診斷與處理
  13. We report a rare, hyperkeratotic form of porokeratosis of mibelli in a patient with hepatocellular cell carcinoma, hepatitis b and recurrent hypoglycemia

    我們報告一位患有肝細胞癌、 b型肝炎以及反覆性低血糖的病人，身上同時有罕見的過度角化型米貝利汗孔角化癥的皮膚病變。
  14. Conclusion : for hcc patients with hb chronic infection / exposure, a high iral load prior to treatment is an aderse factor for surial and may be associated with a higher incidence of seere hepatitis during chemotherapy

    結論:有慢性乙肝感染或接觸史的肝細胞性肝癌患者，化療之前有高病毒負荷量是其生存的負面因素，並與化療期間急性肝炎的高發生率相關
  15. Increased understanding of extrahepatic collateral pathways, superselective embolization, and appropriate selection of embolizing agent with suitable particle size should improve the quality of post - tace care

    經由對肝外側枝循環血管的了解、超選擇性的栓塞、適當的栓塞劑，以及適當大小的栓塞劑顆粒，可以提升肝細胞癌病人接受經導管動脈化學栓塞治療的照護品質。
  16. Hcc is a common cause of morbidity and mortality. for patients who are not candidates for curatie surgery, systemic chemotherapy is one of the standard treatments

    肝細胞性肝癌是發病和死亡的常見原因.對于不能手術切除腫瘤的患者，予全身化療是標準治療方案之一
  17. Future strategies to improe the prognosis of hcc patients undergoing chemotherapy should consider supportie therapy that incorporates antiiral therapies to reduce hb iral load

    將來要改善肝細胞性肝癌化療患者預后的措施應考慮同時給予減少病毒負荷量的抗病毒輔助治療
  18. A very rare case of hepatocellular carcinoma ( hcc ) extending within the common bile duct ( cbd ) and left intrahepatic duct ( ihd ) with no detectable primary hepatic tumor in a 52 - year - old taiwanese man is reported

    摘要肝細胞癌（肝癌）是國內惡性腫瘤死因中的第一位，住院的大型肝癌患者常見癥狀包括腹痛、食欲不振、體重減輕、腹脹、全身虛弱、腹部腫塊、發燒等。
  19. After yellow aspergillus toxin enters the person ' s liver, be released to issue the part that has active by splitting decomposition, action at liver cell, have the effect that cause cancer

    黃麴黴毒素進入人的肝臟后被裂解釋放出具有活性的成分，作用於肝細胞，具有致癌作用。
  20. It has been suggested that patients with hepatocellular carcinoma ( hcc ) undergoing living donor liver transplantation ( ldlt ) have worse recurrence - free survival compared to deceased donor liver transplantation ( clt ), leading to the hypothesis that short waitlist time or fast - tracking may include more aggressive tumors that would have been selected out by traditionally longer waitlist time

    因有已經提議認為肝細胞癌的患者，接受活體供體肝移植的相對于屍體供體肝移植而言，有更壞的存活期無復發率（即更快的移植后復發率） ，導致了認為可能包括更有侵襲性的腫瘤的患者應該在傳統的長時間等待名單上被挑選出來，以短暫等待時間或者快速示蹤（的方式盡快接受肝移植的）假說。
分享友人
分享到 Line

分享到臉書